Value creation in life sciences – 19: Musings with Reto Naef
In this video, we will discuss with Reto Naef, how hard it was to raise $34 M as well as other interesting questions such as serendipity in Science etc.
In this video, we will discuss with Reto Naef, how hard it was to raise $34 M as well as other interesting questions such as serendipity in Science etc.
In this video we explain why men tend to forget objects and women don’t. Also, why we keep eating, leading to obesity epidemic. Last but not least, why understanding these has to do with Value creation.
In this video we discuss why we humans do not understand risk. The genes that our ancestors carried are passed down to us , hence our brain is wired to solve ancient problems and not modern ones.
In this video, we discuss scale by providing analogy to why humans don’t grow like HULK. Then we discuss what all companies can do to scale well.
In this video we discuss with Stephan Christgau, Founding partner Eir Ventures about mainly three questions : 1. Serendipity in Life Sciences : How much happenstance play a role and how does he choose the team that has an open-minded…
In this video we chat with Edoardo Negroni to understand his perspective on Value creation, scaling up and responsibility towards patients. Edoardo is the Co-Founder and Managing partner of AurorA Science, a biotech investment company which invests with the aim…
In this video, we discuss how the realised function of a system changes as we scale bigger. If you are a small company and suddenly become big, if not well planned, this could change its realised function and could lead…
In this video we discuss the fundamentals of Scale, its meaning and try to find out how things scale as they grow. This gives us a food for thought to understand the non-linearity associated with growth in size.
In this video we discuss that VC investment is expensive and hence companies must also find out more about what types of Investors they are, how good are their networks, how decisions are made in partnerships – do the investor…
In this video we discuss how to view these two investments if you are the CEO of a Biotech company. Both have certain pros and cons and depending on your stage of the company, capital needs, you could choose either…